Sovran Advisors LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 464 shares of the medical equipment provider’s stock, valued at approximately $250,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Bennett Selby Investments LP boosted its stake in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares during the last quarter. LVW Advisors LLC lifted its holdings in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after acquiring an additional 19 shares during the period. Wesbanco Bank Inc. boosted its position in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares during the last quarter. Journey Strategic Wealth LLC grew its stake in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after purchasing an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 19 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts recently weighed in on ISRG shares. Piper Sandler reissued an “overweight” rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Leerink Partners raised their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. BTIG Research upped their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Finally, Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $613.10.
Insiders Place Their Bets
In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now owns 353 shares of the company’s stock, valued at $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock valued at $3,587,582 in the last quarter. Corporate insiders own 0.90% of the company’s stock.
Intuitive Surgical Trading Up 0.3 %
Shares of NASDAQ ISRG opened at $591.39 on Friday. The business has a 50-day moving average of $557.70 and a 200-day moving average of $517.49. The firm has a market capitalization of $210.64 billion, a price-to-earnings ratio of 92.26, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- How to Invest in Biotech Stocks
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- How to Use the MarketBeat Excel Dividend Calculator
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Why Are Stock Sectors Important to Successful Investing?
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.